Infusion pumps company InfuSystem Holdings Inc (NYSE American:INFU) revealed on Thursday the election of Richard DiIorio as its president and chief executive officer.
Effective immediately, DiIorio has been elected to serve on the company's board of directors and the Office of the President will cease to operate.
Prior to the promotion, DiIorio has served as a member of the company's Office of the President since May 2017 as well as general manager of Oncology since December 2016.
Previously at the company, DiIorio has served as executive vice president of Oncology Sales from July 2014 to November 2016, regional vice president and vice president Strategic Development from August 2010 to July 2014 as well as territory manager until July 2010.
Earlier in his career, DiIorio held various sales and sales leadership roles at Stryker Medical, Novartis Pharmaceuticals as well as Thermo Scientific.
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer
I Peace generates human iPS cells from NKT cells and offers them for research use
Frontage expands early phase clinical research capabilities across US and China
Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA
InSysBio agrees new collaborative project with BeOne Medicines
Physiomics secures new modelling contract with Numab Therapeutics
Mabwell reports first patient dosed with 7MW4911 in US trial
Atossa Therapeutics' founder and CEO named one of The Top 50 Healthcare Technology CEOs of 2025
Avacta secures FDA clearance for second pre|CISION oncology programme
Guardant Health and Merck enter multi-year oncology diagnostics collaboration
Akeso secures NMPA review acceptance for gumokimab in ankylosing spondylitis